<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03320044</url>
  </required_header>
  <id_info>
    <org_study_id>PTHO1702</org_study_id>
    <nct_id>NCT03320044</nct_id>
  </id_info>
  <brief_title>Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing</brief_title>
  <official_title>Genetic Variations,Immuno-sequencing and Circulating Tumor DNA(ctDNA) for Early Diagnosis of Small Pulmonary Nodules</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University People's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Analyse immune repertoire and genetic mutations of benign and malignant pulmonary nodule，and
      evaluate peripheral blood detection for identifying nature of pulmonary nodule.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Early diagnosis of lung cancer is of vital importance in lung cancer treatment. This research
      will first analyse the features of immune repertoire and genetic mutations from tissue of
      benign and malignant pulmonary nodule，then explore the feasibility of detecting these
      features from peripheral blood sample, and finally evaluate peripheral blood detection of
      lung cancer related immune repertoire and genetic mutations for identifying nature of
      pulmonary nodule.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 18, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The sensitivity and specificity of combining peripheral plasma circulating tumor DNA and white cell immuno-sequencing in diagnosis of early stage non-small cell lung cancer</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The sensitivity and specificity of tissue immune repertoire in diagnosis of early stage non-small cell lung cancer</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The concordance of peripheral plasma circulating tumor DNA and tumor tissue DNA in diagnosis of early stage non-small cell lung cancer</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Carcinoma</condition>
  <condition>Non-small-cell Lung Cancer</condition>
  <condition>Lung Neoplasm</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sample from patient with small pulmonary nodule before surgery.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patient are found small nodules in pulmonary and prepare for surgery
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Sign informed consent and consent to participate in this study;

          2. Found small nodules in pulmonary by CT and prepare for surgery;

        Exclusion Criteria:

          1. Malignant tumor history within the past 5 years;

          2. Receiving chemotherapy, radiotherapy or targeted therapy before surgery;

          3. Histology confirmed not non-small cell lung cancer

          4. No matching tissue or blood samplesUnqualified blood samples
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jun Wang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kezhong Chen, M.D.</last_name>
    <phone>（+86）13488752289</phone>
    <email>mdkzchen@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Heng Zhao, M.D.</last_name>
    <phone>（+86）13683139396</phone>
    <email>zhaohengzhaoheng@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking University People's Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kezhong Chen, M.D.</last_name>
      <phone>+8613488752289</phone>
      <email>mdkzchen@163.com</email>
    </contact>
    <investigator>
      <last_name>Jun Wang, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 20, 2017</study_first_submitted>
  <study_first_submitted_qc>October 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 24, 2017</study_first_posted>
  <last_update_submitted>December 3, 2017</last_update_submitted>
  <last_update_submitted_qc>December 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University People's Hospital</investigator_affiliation>
    <investigator_full_name>Jun Wang</investigator_full_name>
    <investigator_title>Chief，Thoracic Surgery Service</investigator_title>
  </responsible_party>
  <keyword>Circulating Tumor DNA</keyword>
  <keyword>Lung cancer Surgery</keyword>
  <keyword>early diagnosis</keyword>
  <keyword>immuno-sequencing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Multiple Pulmonary Nodules</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

